Australia's most trusted
source of pharma news
Monday, 16 March 2026
Monday, 16 March 2026
Subscribe
Login
12 drugs in PBS limbo pileup
Twelve drugs that secured a recommendation at the PBAC's November 2025 meeting have since stalled in the PBS listing process with the submissions for reimbursement marked inactive.
Dept seeks expansion for big drugs
The DoH has asked PBAC to expand two blockbuster drugs, moving them to the first line, after a sponsor was knocked back
TODAY
$57M J&J drug under threat
The TGA has approved the first generic of this J&J PBS listed drug while a second generic brand circles a BioMarin's medicine
TODAY Approvals Action
Minister wins blockbuster price cut case
Gilead has lost a court battle to protect three drugs earning $164 million a year from follow-on statutory price cuts
13 March
Last ditch effort to keep exclusivity
Stage set for a High Court showdown over a ruling that has shortened exclusivity for a swath of drugs across the industry
13 March
CEO flying in for Aussie TV spot
In a televised address, Novo CEO Mike Doustdar will appeal to Australia to take a leadership role in the global effort to prevent chronic disease
12 March
New PBS drug pulls out of Australia
Long time listing... short time listed. First-in-class drug subsided for just half the time the sponsor spent getting it listed
11 March
Latest Jobs
Customer Service RepresentativePractice ManagerAccount ManagerRegulatory Affairs SpecialistBusiness Development Manager | Community CareDirector of OperationsPharmacovigilance AssociateRegulatory Affairs Specialist19 more...
Pharma in Focus Jobs
Marketing & Communications (1)
Sales & Customer Relations (10)
- Customer Service Representative - St Leonards
- Account Manager - Sydney
- Business Development Manager | Community Care - Queensland
- Pharmaceutical Sales Representative - Sydney
- Devices Account Manager - Sydney
- Customer Service Representative - Pemulwuy
- Customer Service Representative - St Leonards
- Pharmaceutical Sales Representative - Brisbane
- Customer Service Specialist - Frenchs Forest
- Customer Service Representative - St Leonards
Clinical & Medical, R&D (2)
- Senior Manager, Clinical Operations (Japan) - Tokyo, Japan
- Senior Clinical Project Manager - Tokyo, Japan
Regulatory, Pharmacovigilance & QA (6)
- Regulatory Affairs Specialist - Lane Cove
- Pharmacovigilance Associate - Sydney
- Regulatory Affairs Specialist - Glenorie
- Senior Manager, Regulatory Affairs Operations - Tokyo, Japan
- Associate Director Regulatory Operations (Japan) - Tokyo, Japan
- Regulatory & Quality Manager - Melbourne
Devices (1)
Executive Roles (4)
- Director of Operations - Melbourne
- Senior Manager, Regulatory Affairs Operations - Tokyo, Japan
- Associate Director Regulatory Operations (Japan) - Tokyo, Japan
- Senior Manager, Clinical Operations (Japan) - Tokyo, Japan
Other (8)
New drug disappears from PBS
ICYMI: The disappearing act of a first-in-class PBS drug listed for just 14 months plus the other most popular stories this week
13 March Your Week in 5 Minutes
PBS is "like handwriting letters"
AbbVie GM tells a future leadership summit that PBS processes are stuck deep in the past, blocking access to scientific advances
13 March
Pain Institute launches in Australia
Bringing together clinical and academic expertise to develop ways to support HCPs and patients improve pain outcomes
13 March
US backs drug with $21M injection
US government agency backs Aussie-led project developing the first oral therapeutic for restoring gut lymphatic function
12 March
Is pharma simply too risk averse?
Australia pharma leaders are worried that industry is too cautious when it comes to driving cross-functional digital transformation
12 March
New front in $100M legal fight
Generic company takes a new tack in its bid to launch into a lucrative market, claiming a patent extension should never have been granted
12 March
Heart drug launches in Australia
The fast-acting, short half-life drug gives HCPs greater precision in treating people with elevated heart rates in the acute setting
12 March
Hidden hazards of Hybrid Work
The "sugar hit" of working from home could be fading for some with boundary erosion sending workloads and work hours soaring
11 March
Pharma ups its game in hot market
Company adds self-injectable version of its treatment being considered by the reimbursement committee this week
11 March
Report exposes nuclear meds crisis
Industry stakeholders unite in call for urgent reform of Australia's nuclear medicines sector, with a National Action Plan launched
11 March
CSL's $1.5 billion US expansion
The local giant is investing $1.5 billion in manufacturing capacity to meet growing demand in rare diseases
11 March
Who forgot to pay the patent renewal?
A pharma has narrowly avoided losing patent exclusivity after a chain of outsourcing saw a breakdown in communication
10 March
Homegrown CAR T therapy debuts
An Australian team is hoping to crack the blood cancer market, with other candidates in the pipeline for solid organ cancers
10 March
17 new drug labels under review
TGA reviewing new indications spanning a range of therapeutic areas, including cardiovascular, oncology, and immunology
10 March